Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population
By identifying these structural changes prior to the onset of symptomatic neurodegeneration, providers may be able to initiate preventive therapies sooner.
Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent
Subsidiary RayzeBio has inked a definitive deal to license the worldwide rights for the drug from Philochem, a Swiss biotechnology firm.
FDA issues recall of Philips interventional imaging system due to safety risks
A communication error within the system can reportedly cause loss of imaging functionality mid-procedure.
FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging
The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.
A new payer tactic: Using AI to curtail routine radiology claims, after imaging is already delivered
“Unlike [prior authorization], this model does not delay patient care and does not hold members liable to pay for unneeded exams,” writes radiologist Mark Hiatt, MD, MBA.

Novel biomarker looks for diabetic retinopathy

A targeted molecular imaging technique could aid in the prevention of blindness associated with progressive diabetic neuropathy by tracking alterations in the retinal endothelium, the Federation of American Societies for Experimental Biology (FASEB) announced yesterday.

Vizamyl wins European approval

The amyloid PET radiotracer F-18 flutemetamol (Vizamyl) has been given the CE mark from the European Commission authorizing marketing of the drug across Europe, GE Healthcare announced yesterday.

Cancer screening bias casts a shadow on clinical decision making

In the world of cancer screening, there may be a bias of accessibility that is skewed toward more screening when doctors are paid more by Medicaid, according to a study conducted by the division of health services and social policy research at RTI International in Washington, D.C.

Measuring perfusion defects in SPECT MPI: A quantitative comparison

Three major quantitative softwares offer cardiologists a comprehensive map of myocardial perfusion and function, but they do not always agree, according to a study in the August issue of the Journal of Nuclear Cardiology.

Quantitative F-18 Flute PET provides more data about brain amyloid

F-18 Flutemetamol (F-18 Flute) alone has been used to procure positive or negative results in visual interpretations of beta-amyloid in the brain as a tool to aid in the diagnosis and study of Alzheimer’s disease. Quantitative analysis could further supercharge this technique by bringing in more data about regional and total tracer uptake, according to a study published Aug. 21 in the Journal of Nuclear Medicine.

Radiant Sage named on CIOReview list of 100 most promising technology companies

Radiant Sage LLC, a provider of on-demand clinical trial imaging infrastructure solutions, today announced that it has been named to CIOReview's list of 100 Most Promising Technology Companies. The CIOReview100 includes companies that are gaining momentum in the technology industry and making an impact.

Gene therapy acts as a protector against fatal heart condition

A dangerous heart condition associated with muscular dystrophy could one day be treated with a gene therapy that protects the heart under stress. Researchers at the University of Missouri are conducting a preclinical study to develop a gene therapy that could be used for treating other heart conditions, the institution announced last week.

Glioma PET: Radiotracers DOPA and FET go head to head

In a direct visual and quantitative comparison of F-18 FET and F-18 DOPA in primary glioma, FET provided more quantitative characterization, but both were successful for tumor delineation, according to a review published Aug. 14 in the Journal of Nuclear Medicine.

Medical Imaging

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population

Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent

FDA issues recall of Philips interventional imaging system due to safety risks

FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

A new payer tactic: Using AI to curtail routine radiology claims, after imaging is already delivered